Is the first-line systemic chemoprevention of nonmelanoma skin cancer nicotinamide or acitretin?

Int J Dermatol. 2021 Jun;60(6):749-750. doi: 10.1111/ijd.15442. Epub 2021 Feb 9.

Authors

Karl M Hoegler¹, Amor Khachemoune^{2

3}

Affiliations

¹ Department of Dermatology, University of Maryland Medical Center, Baltimore, MD, USA.
² Brooklyn Campus of the VA NY Harbor Healthcare System, Brooklyn, NY, USA.
³ Department of Dermatology, SUNY Downstate, Brooklyn, NY, USA.

PMID: 33565095
DOI: 10.1111/ijd.15442

No abstract available

MeSH terms

Acitretin* / therapeutic use
Chemoprevention
Humans
Niacinamide / therapeutic use
Skin Neoplasms* / drug therapy
Skin Neoplasms* / prevention & control

Substances

Niacinamide
Acitretin